Now showing items 1-1 of 1
The identification of biomarker differences between grade I and II meningiomas: Fibulin-2 is a novel biomarker for differentiating grade II from grade I meningiomas
(University of Plymouth, 2021)
Background: There is an unmet need for the identification of biomarkers to aid in the diagnosis, clinical management, prognosis and follow-up of meningiomas, facilitated by recent advances in meningioma genomics. WHO grade ...